In a historic move, Publicis, a French advertising company, has agreed to a $350 million settlement over its alleged role in the opioid crisis. This marks the first time an advertising firm has been held accountable for its part in the epidemic.
BD exceeds expectations with Q1 2024 adjusted EPS of $2.68 (vs $2.40 consensus). William Blair maintains a positive outlook, confident in BD's progress towards its 2025.
Takeda Pharmaceutical's Q3 2023 results: ¥235.9 billion core net profit, management changes, and a global collaboration deal for rusfertide. Fiscal year 2023 guidance reiterated.